US 11,957,888 B2
Personalizing preset meal sizes in insulin delivery system
Lane Desborough, Thousand Oaks, CA (US); Bryan Mazlish, Palo Alto, CA (US); Andrew Bochenko, Redwood City, CA (US); Ross Naylor, Fullerton, CA (US); Jeff Boissier, San Jose, CA (US); and Sabine Kabel-Eckes, Mountain View, CA (US)
Assigned to Bigfoot Biomedical, Inc., Milpitas, CA (US)
Filed by Bigfoot Biomedical, Inc., Milpitas, CA (US)
Filed on Jan. 11, 2022, as Appl. No. 17/647,688.
Application 17/647,688 is a continuation of application No. 15/717,845, filed on Sep. 27, 2017, granted, now 11,229,751.
Claims priority of provisional application 62/400,366, filed on Sep. 27, 2016.
Prior Publication US 2022/0134017 A1, May 5, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. G06F 3/04817 (2022.01); A61M 5/172 (2006.01); A61M 5/32 (2006.01); G06F 3/0482 (2013.01); G06F 3/04847 (2022.01); G16H 20/10 (2018.01); G16H 20/17 (2018.01); G16H 50/20 (2018.01); G06F 3/04883 (2022.01); G16H 10/60 (2018.01); G16H 40/63 (2018.01)
CPC A61M 5/3202 (2013.01) [A61M 5/1723 (2013.01); G06F 3/04817 (2013.01); G06F 3/0482 (2013.01); G06F 3/04847 (2013.01); G16H 20/10 (2018.01); G16H 20/17 (2018.01); G16H 50/20 (2018.01); A61M 2205/3303 (2013.01); A61M 2205/3306 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/50 (2013.01); A61M 2205/505 (2013.01); A61M 2205/52 (2013.01); A61M 2230/201 (2013.01); G06F 3/04883 (2013.01); G16H 10/60 (2018.01); G16H 40/63 (2018.01)] 18 Claims
OG exemplary drawing
 
1. An insulin delivery system comprising:
an insulin delivery device;
a mobile device in communication with the insulin delivery device, the mobile device comprising:
a user interface;
at least one processor; and
at least one non-transitory computer-readable storage medium storing instructions thereon that, when executed by the at least one processor, cause the mobile device to:
display a plurality of user-selectable elements, each user-selectable element representing a respective meal size and associated with a respective different amount of carbohydrates;
determine a respective insulin delivery amount deliverable responsive to selection of a respective user-selectable element and determined based at least partially on the amount of carbohydrates associated with the respective user selectable element;
subsequent to a delivery of insulin according to the respective insulin delivery amounts, receive blood glucose data from a blood glucose monitor;
based at least partially on the received blood glucose data, identify a blood glucose level trend over a time period; and
based at least partially on the identified blood glucose level trend, automatically, without any user intervention, associate at least one user selectable element of the plurality of user-selectable elements with a respective new amount of carbohydrates that is different than the respective different amount of carbohydrates previously associated with the at least one user selectable element of the plurality of user-selectable elements and different than the respective different amount of carbohydrates associated with respective ones of the other user-selectable elements of the plurality of user-selectable elements.